-Advertisement-
-Advertisement-
Conference Roundup

Maralixibat well tolerated in patients with ALGS in real-world setting
Patients with ALGS treated with maralixibat in a real-world analysis had lower rates of adverse events (AEs) than described in clinical trials, according to data presented at The Liver Meeting of the American Association for the Study of Liver Diseases. Real-world safety data from all patients treated with maralixibat through...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 MedJournal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved